Anterix (ATEX)
(Real Time Quote from BATS)
$38.44 USD
+0.33 (0.87%)
Updated Sep 25, 2024 11:58 AM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for Anterix Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 4 | 2 | 1 | 1 | 2 |
Cost Of Goods | 0 | 0 | 0 | 2 | 3 |
Gross Profit | 4 | 2 | 1 | -1 | -1 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 18 | 38 | 54 | 36 |
Income After Depreciation & Amortization | -10 | -16 | -37 | -55 | -37 |
Non-Operating Income | 3 | 1 | 0 | 1 | 2 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -8 | -15 | -37 | -54 | -35 |
Income Taxes | 2 | 1 | 1 | 0 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -16 | -38 | -54 | -38 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -16 | -38 | -54 | -38 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -15 | -35 | -51 | -34 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 4 | 4 |
Income After Depreciation & Amortization | -10 | -16 | -37 | -55 | -37 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 18.77 | 18.84 | 18.14 | 17.41 | NA |
Diluted EPS Before Non-Recurring Items | -0.49 | -2.33 | -2.07 | -3.13 | NA |
Diluted Net EPS (GAAP) | -0.49 | -0.87 | -2.07 | -3.13 | -2.29 |
Fiscal Year end for Anterix Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1.53 | 1.26 | 1.27 | 1.05 | 0.61 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1.53 | 1.26 | 1.27 | 1.05 | 0.61 |
SG&A, R&D, and Dept/Amort Expenses | 16.54 | 11.77 | 0.31 | -1.20 | 3.45 |
Income After SG&A, R&D, and Dept/Amort Expenses | -15.01 | -10.51 | 0.96 | 2.25 | -2.84 |
Non-Operating Income | 0.71 | 0.97 | 0.70 | 0.46 | 0.48 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -14.30 | -9.54 | 1.67 | 2.72 | -2.36 |
Income Taxes | 1.22 | -0.13 | 1.34 | 0.65 | -0.24 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -15.52 | -9.41 | 0.33 | 2.07 | -2.12 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -15.52 | -9.41 | 0.33 | 2.07 | -2.12 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 18.49 | 18.48 | 18.92 | 19.11 | 18.95 |
Diluted EPS Before Non-Recurring Items | -0.84 | -0.51 | -0.55 | -0.55 | -0.11 |
Diluted Net EPS (GAAP) | -0.84 | -0.51 | 0.02 | 0.11 | -0.11 |